CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia

There is an unmet need for markers that can stratify different forms and subtypes of dementia. Because of similarities in clinical presentation, it can be difficult to distinguish between Alzheimer's disease (AD) and frontotemporal dementia (FTD). Using a multiplex targeted proteomic LC-MS/MS p...

Descripción completa

Detalles Bibliográficos
Autores principales: Heywood, Wendy E., Hallqvist, Jenny, Heslegrave, Amanda J., Zetterberg, Henrik, Fenoglio, Chiara, Scarpini, Elio, Rohrer, Jonathan D., Galimberti, Daniela, Mills, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221294/
https://www.ncbi.nlm.nih.gov/pubmed/30292090
http://dx.doi.org/10.1016/j.neurobiolaging.2018.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221294/
https://www.ncbi.nlm.nih.gov/pubmed/30292090
http://dx.doi.org/10.1016/j.neurobiolaging.2018.08.019

Ejemplares similares